The evolving landscape of digital inhaler platforms and adherence support in chronic airways disease
Chronic Respiratory Disease · 2025-08 · 22
DOI: 10.1177/14799731251366969 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chronic Respiratory Disease, online erschienen am 08.08.2025. Verfasst von Hnin Wint Wint Aung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Sciences, University of Leicester, Leicester, UK. Hauptthemen laut MEDLINE: Nebulizers and Vaporizers, Medication Adherence, Pulmonary Disease, Chronic Obstructive, Asthma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute for Health and Care Research, Leicester Biomedical Research Centre.
Abstract (Originalsprache)
Inhaled therapies remain the cornerstone in managing chronic airway diseases, offering direct treatment delivery to the lungs with minimal systemic adverse effects. With advancements in respiratory care, digital inhalers have emerged as a transformative innovation. Their functions extend beyond delivering inhaled medication, providing deeper insights into patients’ medication use behaviour and intervening through complementary platform features and integrated data analytics. However, despite being available for over two decades, the widespread adoption of digital inhaler platforms remains limited due to uncertainties regarding their cost-effectiveness, feasibility in real-world settings, and concerns regarding sustainability. Identifying patient groups that could benefit most from these technologies and designing strategies for effective deployment across diverse healthcare contexts is important. To achieve this, bridging the gap between innovation and accessibility is required so that digital inhaler platforms evolve into inclusive, patient-centred tools rather than niche technologies. This narrative review provides a summary of the evolution and current landscape of digital inhaler technology, its impact on clinical outcomes in chronic airway disease, and key challenges that stakeholders should address for the successful integration of these tools into respiratory care. We also propose key components of a patient-centred digital inhaler adherence support model that prioritises accessibility and efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Sciences, University of Leicester, Leicester, UK.
- Institute for Lung Health, NIHR Respiratory Biomedical Research Centre, University Hospitals of Leicester, UK.
- School of Pharmacy, DeMontfort University, Leicester, UK.
ORCID-Profile: Hnin Wint Wint Aung
Förderung
- National Institute for Health and Care Research
- Leicester Biomedical Research Centre
Zitieren
APA
Aung, H. W. W., Murphy, A., & Greening, N. J. (2025). The evolving landscape of digital inhaler platforms and adherence support in chronic airways disease. Chronic Respiratory Disease, 22. https://doi.org/10.1177/14799731251366969
Vancouver
Aung HWW, Murphy A, Greening NJ. The evolving landscape of digital inhaler platforms and adherence support in chronic airways disease. Chronic Respiratory Disease. 2025;22. doi:10.1177/14799731251366969
BibTeX
@article{Aung2025,
author = {Aung, Hnin Wint Wint and Murphy, Anna and Greening, Neil J},
title = {The evolving landscape of digital inhaler platforms and adherence support in chronic airways disease},
journal = {Chronic Respiratory Disease},
year = {2025},
volume = {22},
doi = {10.1177/14799731251366969}
}
EUVIMED